{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T00:31:44Z","timestamp":1790469104004,"version":"4.1.0"},"reference-count":147,"publisher":"Elsevier BV","issue":"30","license":[{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001807","name":"FAPESP","doi-asserted-by":"publisher","award":["14\/50981-0"],"award-info":[{"award-number":["14\/50981-0"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"CNPq","doi-asserted-by":"publisher","award":["301229\/2017-1"],"award-info":[{"award-number":["301229\/2017-1"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"CNPq","doi-asserted-by":"publisher","award":["441449\/2014-0"],"award-info":[{"award-number":["441449\/2014-0"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005942","name":"Funda\u00e7\u00e3o Butantan","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005942","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2019,7]]},"DOI":"10.1016\/j.vaccine.2019.05.087","type":"journal-article","created":{"date-parts":[[2019,6,8]],"date-time":"2019-06-08T16:22:37Z","timestamp":1560010957000},"page":"3961-3973","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"title":["Adjuvanted leptospiral vaccines: Challenges and future development of new leptospirosis vaccines"],"prefix":"10.1016","volume":"37","author":[{"given":"Aline F.","family":"Teixeira","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis G.V.","family":"Fernandes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria F.","family":"Cavenague","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria B.","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jademilson C.","family":"Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felipe J.","family":"Passalia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brenda B.","family":"Daroz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leandro T.","family":"Kochi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica L.","family":"Vieira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana L.T.O.","family":"Nascimento","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2019.05.087_b0005","unstructured":"WHO. Assessment report of the global vaccine action plan; 2018."},{"key":"10.1016\/j.vaccine.2019.05.087_b0010","doi-asserted-by":"crossref","first-page":"2562","DOI":"10.2174\/15680266113136660183","article-title":"Vaccine adjuvants: key tools for innovative vaccine design","volume":"13","author":"Riese","year":"2013","journal-title":"Curr Top Med Chem"},{"key":"10.1016\/j.vaccine.2019.05.087_b0015","doi-asserted-by":"crossref","first-page":"51","DOI":"10.4110\/in.2015.15.2.51","article-title":"Recent advances of vaccine adjuvants for infectious diseases","volume":"15","author":"Lee","year":"2015","journal-title":"Immune Netw"},{"key":"10.1016\/j.vaccine.2019.05.087_b0020","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1007\/s12272-017-0969-z","article-title":"Vaccine adjuvants: smart components to boost the immune system","volume":"40","author":"Bastola","year":"2017","journal-title":"Arch Pharm Res"},{"key":"10.1016\/j.vaccine.2019.05.087_b0025","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1002\/cmdc.201200487","article-title":"Modern subunit vaccines: development, components, and research opportunities","volume":"8","author":"Moyle","year":"2013","journal-title":"ChemMedChem"},{"key":"10.1016\/j.vaccine.2019.05.087_b0030","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bcp.2016.05.001","article-title":"Vaccine technologies: From whole organisms to rationally designed protein assemblies","volume":"120","author":"Karch","year":"2016","journal-title":"Biochem Pharmacol"},{"issue":"Suppl 3","key":"10.1016\/j.vaccine.2019.05.087_b0035","doi-asserted-by":"crossref","first-page":"S266","DOI":"10.1086\/313883","article-title":"Improving vaccine performance with adjuvants","volume":"30","author":"Vogel","year":"2000","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2019.05.087_b0040","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.coi.2013.12.007","article-title":"Immunomodulatory properties of the vaccine adjuvant alum","volume":"28","author":"Oleszycka","year":"2014","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.vaccine.2019.05.087_b0045","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1586\/erv.12.140","article-title":"The history of MF59(\u00ae) adjuvant: a phoenix that arose from the ashes","volume":"12","author":"O'Hagan","year":"2013","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2019.05.087_b0050","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1586\/erv.11.192","article-title":"Development and evaluation of AS03, an Adjuvant System containing \u03b1-tocopherol and squalene in an oil-in-water emulsion","volume":"11","author":"Gar\u00e7on","year":"2012","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2019.05.087_b0055","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1177\/2051013614541440","article-title":"Liposomes as vaccine delivery systems: a review of the recent advances","volume":"2","author":"Schwendener","year":"2014","journal-title":"Ther Adv Vaccines"},{"key":"10.1016\/j.vaccine.2019.05.087_b0060","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1586\/14760584.6.5.723","article-title":"GlaxoSmithKline Adjuvant Systems in vaccines: concepts, achievements and perspectives","volume":"6","author":"Gar\u00e7on","year":"2007","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2019.05.087_b0065","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.smim.2018.05.001","article-title":"Correlates of adjuvanticity: A review on adjuvants in licensed vaccines","volume":"39","author":"Del Giudice","year":"2018","journal-title":"Semin Immunol"},{"key":"10.1016\/j.vaccine.2019.05.087_b0070","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0003898","article-title":"Global morbidity and mortality of leptospirosis: a systematic review","volume":"9","author":"Costa","year":"2015","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.vaccine.2019.05.087_b0075","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0004275","article-title":"Spatiotemporal determinants of urban leptospirosis transmission: four-year prospective cohort study of slum residents in Brazil","volume":"10","author":"Hagan","year":"2016","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.vaccine.2019.05.087_b0080","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1590\/0037-8682-0115-2016","article-title":"Seroprevalence of and risk factors for leptospirosis in the City of Manaus, State of Amazonas","volume":"49","author":"Silva","year":"2016","journal-title":"Brazil. Rev Soc Bras Med Trop"},{"key":"10.1016\/j.vaccine.2019.05.087_b0085","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1086\/340615","article-title":"Outbreak of leptospirosis among triathlon participants and community residents in Springfield, Illinois, 1998","volume":"34","author":"Morgan","year":"2002","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2019.05.087_b0090","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1086\/650578","article-title":"Outbreak of leptospirosis among Adventure Race participants in Florida, 2005","volume":"50","author":"Stern","year":"2010","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2019.05.087_b0095","unstructured":"Faine S, Adler B, Bolin C, Perolat P. Leptospira and Leptospirosis. Melbourne, Australia: MediSci; 1999."},{"key":"10.1016\/j.vaccine.2019.05.087_b0100","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/S1473-3099(03)00830-2","article-title":"Leptospirosis: a zoonotic disease of global importance","volume":"3","author":"Bharti","year":"2003","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2019.05.087_b0105","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1128\/CMR.14.2.296-326.2001","article-title":"Leptospirosis","volume":"14","author":"Levett","year":"2001","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.vaccine.2019.05.087_b0110","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1111\/j.1469-0691.2007.01662.x","article-title":"Safety and immunogenicity of subcutaneous or intramuscular administration of a monovalent inactivated vaccine against Leptospira interrogans serogroup Icterohaemorrhagiae in healthy volunteers","volume":"13","author":"Laurichesse","year":"2007","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.vaccine.2019.05.087_b0115","first-page":"249","article-title":"[Efficacy and safety of a vaccine against human leptospirosis in Cuba]","volume":"15","author":"Mart\u00ednez","year":"2004","journal-title":"Rev Panam Salud Publica"},{"key":"10.1016\/j.vaccine.2019.05.087_b0120","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.cimid.2007.05.003","article-title":"Current status of leptospirosis in Japan and Philippines","volume":"30","author":"Yanagihara","year":"2007","journal-title":"Comp Immunol Microbiol Infect Dis"},{"key":"10.1016\/j.vaccine.2019.05.087_b0125","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1099\/00222615-29-2-115","article-title":"Experimental immunisation of hamsters with lipopolysaccharide antigens of Leptospira interrogans","volume":"29","author":"Jost","year":"1989","journal-title":"J Med Microbiol"},{"key":"10.1016\/j.vaccine.2019.05.087_b0130","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1038\/icb.1974.28","article-title":"A mechanism of immunity to leptospirosis","volume":"52","author":"Faine","year":"1974","journal-title":"Aust J Exp Biol Med Sci"},{"key":"10.1016\/j.vaccine.2019.05.087_b0135","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1128\/iai.17.1.67-72.1977","article-title":"Host immunological mechanisms in the resistance of mice to leptospiral infections","volume":"17","author":"Adler","year":"1977","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2019.05.087_b0140","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1016\/j.vaccine.2004.09.012","article-title":"Aluminium assay and evaluation of the local reaction at several time points after intramuscular administration of aluminium containing vaccines in the Cynomolgus monkey","volume":"23","author":"Verdier","year":"2005","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.05.087_b0145","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1016\/j.vaccine.2004.07.050","article-title":"Role of aluminum-containing adjuvants in antigen internalization by dendritic cells in vitro","volume":"23","author":"Morefield","year":"2005","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.05.087_b0150","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1038\/nature06939","article-title":"Crucial role for the Nalp3 inflammasome in the immunostimulatory properties of aluminium adjuvants","volume":"453","author":"Eisenbarth","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2019.05.087_b0155","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1186\/s40064-015-0972-0","article-title":"The mechanisms of action of vaccines containing aluminum adjuvants: an in vitro vs in vivo paradigm","volume":"4","author":"Ghimire","year":"2015","journal-title":"Springerplus"},{"key":"10.1016\/j.vaccine.2019.05.087_b0160","doi-asserted-by":"crossref","first-page":"5191","DOI":"10.1182\/blood-2010-03-275529","article-title":"Aluminum adjuvants elicit fibrin-dependent extracellular traps in vivo","volume":"116","author":"Munks","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.vaccine.2019.05.087_b0165","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1038\/nm.2403","article-title":"DNA released from dying host cells mediates aluminum adjuvant activity","volume":"17","author":"Marichal","year":"2011","journal-title":"Nat Med"},{"key":"10.1016\/j.vaccine.2019.05.087_b0170","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/febs.13546","article-title":"IL-1\u03b1 and inflammasome-independent IL-1\u03b2 promote neutrophil infiltration following alum vaccination","volume":"283","author":"Oleszycka","year":"2016","journal-title":"FEBS J"},{"key":"10.1016\/j.vaccine.2019.05.087_b0175","doi-asserted-by":"crossref","first-page":"2062","DOI":"10.1002\/eji.1830260915","article-title":"In interleukin-4-deficient mice, alum not only generates T helper 1 responses equivalent to freund's complete adjuvant, but continues to induce T helper 2 cytokine production","volume":"26","author":"Brewer","year":"1996","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.vaccine.2019.05.087_b0180","doi-asserted-by":"crossref","first-page":"114","DOI":"10.3389\/fimmu.2013.00114","article-title":"Mechanisms of action of adjuvants","volume":"4","author":"Awate","year":"2013","journal-title":"Front Immunol"},{"key":"10.1016\/j.vaccine.2019.05.087_b0185","doi-asserted-by":"crossref","first-page":"5069","DOI":"10.4049\/jimmunol.1402915","article-title":"Involvement of CD300a phosphatidylserine immunoreceptor in aluminum salt adjuvant-induced Th2 responses","volume":"194","author":"Miki","year":"2015","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2019.05.087_b0190","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1128\/IAI.74.3.1745-1750.2006","article-title":"Immunoprotection of recombinant leptospiral immunoglobulin-like protein A against Leptospira interrogans serovar Pomona infection","volume":"74","author":"Palaniappan","year":"2006","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2019.05.087_b0195","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1128\/CVI.00285-15","article-title":"Protective immunity and reduced renal colonization induced by vaccines containing recombinant leptospira interrogans outer membrane proteins and flagellin adjuvant","volume":"22","author":"Monaris","year":"2015","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.vaccine.2019.05.087_b0200","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0005441","article-title":"LigB subunit vaccine confers sterile immunity against challenge in the hamster model of leptospirosis","volume":"11","author":"Conrad","year":"2017","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.vaccine.2019.05.087_b0205","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1126\/science.286.5438.291","article-title":"Crystal structure of invasin: a bacterial integrin-binding protein","volume":"286","author":"Hamburger","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.vaccine.2019.05.087_b0210","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1038\/35016618","article-title":"Crystal structure of enteropathogenic Escherichia coli intimin-receptor complex","volume":"405","author":"Luo","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2019.05.087_b0215","doi-asserted-by":"crossref","first-page":"5249","DOI":"10.1021\/bi500669u","article-title":"NMR solution structure of the terminal immunoglobulin-like domain from the leptospira host-interacting outer membrane protein, LigB","volume":"53","author":"Ptak","year":"2014","journal-title":"Biochemistry"},{"key":"10.1016\/j.vaccine.2019.05.087_b0220","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1002\/bit.26864","article-title":"Comparative screening of recombinant antigen thermostability for improved leptospirosis vaccine design","volume":"116","author":"Ptak","year":"2019","journal-title":"Biotechnol Bioeng"},{"key":"10.1016\/j.vaccine.2019.05.087_b0225","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1046\/j.1365-2958.2003.03619.x","article-title":"Pathogenic Leptospira species express surface-exposed proteins belonging to the bacterial immunoglobulin superfamily","volume":"49","author":"Matsunaga","year":"2003","journal-title":"Mol Microbiol"},{"key":"10.1016\/j.vaccine.2019.05.087_b0230","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1099\/jmm.0.45568-0","article-title":"Expression of leptospiral immunoglobulin-like protein by Leptospira interrogans and evaluation of its diagnostic potential in a kinetic ELISA","volume":"53","author":"Palaniappan","year":"2004","journal-title":"J Med Microbiol"},{"key":"10.1016\/j.vaccine.2019.05.087_b0235","doi-asserted-by":"crossref","first-page":"5924","DOI":"10.1128\/IAI.70.11.5924-5930.2002","article-title":"Cloning and molecular characterization of an immunogenic LigA protein of Leptospira interrogans","volume":"70","author":"Palaniappan","year":"2002","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2019.05.087_b0240","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.micinf.2008.11.008","article-title":"Immunogenicity and protective efficacy of recombinant Leptospira immunoglobulin-like protein B (rLigB) in a hamster challenge model","volume":"11","author":"Yan","year":"2009","journal-title":"Microbes Infect"},{"key":"10.1016\/j.vaccine.2019.05.087_b0245","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1128\/CVI.00601-12","article-title":"A conserved region of leptospiral immunoglobulin-like A and B proteins as a DNA vaccine elicits a prophylactic immune response against leptospirosis","volume":"20","author":"Forster","year":"2013","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.vaccine.2019.05.087_b0250","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1590\/0074-02760150222","article-title":"DNA prime-protein boost based vaccination with a conserved region of leptospiral immunoglobulin-like A and B proteins enhances protection against leptospirosis","volume":"110","author":"Forster","year":"2015","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"10.1016\/j.vaccine.2019.05.087_b0255","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1590\/0074-02760160214","article-title":"Immune response in hamsters immunised with a recombinant fragment of LigA from Leptospira interrogans, associated with carrier molecules","volume":"111","author":"Oliveira","year":"2016","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"10.1016\/j.vaccine.2019.05.087_b0260","doi-asserted-by":"crossref","first-page":"3413","DOI":"10.1016\/j.vaccine.2011.02.084","article-title":"Recombinant LipL32 and LigA from Leptospira are unable to stimulate protective immunity against leptospirosis in the hamster model","volume":"29","author":"Lucas","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.05.087_b0265","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1128\/CVI.00719-13","article-title":"Vaccination with leptospiral outer membrane lipoprotein LipL32 reduces kidney invasion of Leptospira interrogans serovar canicola in hamsters","volume":"21","author":"Humphryes","year":"2014","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.vaccine.2019.05.087_b0270","doi-asserted-by":"crossref","first-page":"4958","DOI":"10.1128\/IAI.69.8.4958-4968.2001","article-title":"Leptospiral proteins recognized during the humoral immune response to leptospirosis in humans","volume":"69","author":"Guerreiro","year":"2001","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2019.05.087_b0275","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1038\/nature08184","article-title":"Proteome-wide cellular protein concentrations of the human pathogen Leptospira interrogans","volume":"460","author":"Malmstr\u00f6m","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2019.05.087_b0280","doi-asserted-by":"crossref","first-page":"6572","DOI":"10.1128\/IAI.67.12.6572-6582.1999","article-title":"Leptospiral outer membrane proteins OmpL1 and LipL41 exhibit synergistic immunoprotection","volume":"67","author":"Haake","year":"1999","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2019.05.087_b0285","doi-asserted-by":"crossref","first-page":"4936","DOI":"10.1128\/IAI.70.9.4936-4945.2002","article-title":"Characterization of the leptospiral outer membrane and description of three novel leptospiral membrane proteins","volume":"70","author":"Haake","year":"2002","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2019.05.087_b0290","doi-asserted-by":"crossref","first-page":"4225","DOI":"10.1128\/jb.175.13.4225-4234.1993","article-title":"Molecular cloning and sequence analysis of the gene encoding OmpL1, a transmembrane outer membrane protein of pathogenic Leptospira spp","volume":"175","author":"Haake","year":"1993","journal-title":"J Bacteriol"},{"key":"10.1016\/j.vaccine.2019.05.087_b0295","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/1471-2180-11-21","article-title":"Characterization of conserved combined T and B cell epitopes in Leptospira interrogans major outer membrane proteins OmpL1 and LipL41","volume":"11","author":"Lin","year":"2011","journal-title":"BMC Microbiol"},{"key":"10.1016\/j.vaccine.2019.05.087_b0300","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1186\/s12866-016-0852-y","article-title":"Chimeric epitope vaccine against Leptospira interrogans infection and induced specific immunity in guinea pigs","volume":"16","author":"Lin","year":"2016","journal-title":"BMC Microbiol"},{"key":"10.1016\/j.vaccine.2019.05.087_b0305","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.ijid.2017.01.032","article-title":"Immune response and protective profile elicited by a multi-epitope chimeric protein derived from Leptospira interrogans","volume":"57","author":"Fernandes","year":"2017","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.vaccine.2019.05.087_b0310","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1099\/jmm.0.021485-0","article-title":"Characterization of leptospiral proteins that afford partial protection in hamsters against lethal challenge with Leptospira interrogans","volume":"59","author":"Atzingen","year":"2010","journal-title":"J Med Microbiol"},{"key":"10.1016\/j.vaccine.2019.05.087_b0315","doi-asserted-by":"crossref","first-page":"2026","DOI":"10.1128\/CVI.05297-11","article-title":"Subunit approach to evaluation of the immune protective potential of leptospiral antigens","volume":"18","author":"F\u00e9lix","year":"2011","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.vaccine.2019.05.087_b0320","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0142821","article-title":"Evaluation of the leptospira interrogans outer membrane protein OmpL37 as a vaccine candidate","volume":"10","author":"Oliveira","year":"2015","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2019.05.087_b0325","doi-asserted-by":"crossref","first-page":"1813745","DOI":"10.1155\/2018\/1813745","article-title":"Evaluation of Lsa46 and Lsa77 leptospiral proteins for their immunoprotective activities in hamster model of leptospirosis","volume":"2018","author":"Teixeira","year":"2018","journal-title":"Biomed Res Int"},{"key":"10.1016\/j.vaccine.2019.05.087_b0330","doi-asserted-by":"crossref","first-page":"6447","DOI":"10.1038\/s41598-018-24674-8","article-title":"Heterologous DNA prime-protein boost immunization with RecA and FliD offers cross-clade protection against leptospiral infection","volume":"8","author":"Raja","year":"2018","journal-title":"Sci Rep"},{"key":"10.1016\/j.vaccine.2019.05.087_b0335","first-page":"337","article-title":"GSK's novel split-virus adjuvanted vaccines for the prevention of the H5N1 strain of avian influenza infection","volume":"11","author":"Jones","year":"2009","journal-title":"Curr Opin Mol Ther"},{"key":"10.1016\/j.vaccine.2019.05.087_b0340","doi-asserted-by":"crossref","first-page":"2800","DOI":"10.1016\/j.vaccine.2015.04.027","article-title":"Immunogenicity and safety of an AS03-adjuvanted H5N1 pandemic influenza vaccine in Korean adults: a phase IV, randomized, open-label, controlled study","volume":"33","author":"Izurieta","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.05.087_b0345","doi-asserted-by":"crossref","first-page":"6436","DOI":"10.1016\/j.vaccine.2012.08.005","article-title":"A prospective observational safety study on MF59(\u00ae) adjuvanted cell culture-derived vaccine, Celtura(\u00ae) during the A\/H1N1 (2009) influenza pandemic","volume":"30","author":"Reynales","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.05.087_b0350","first-page":"121","article-title":"Comparison between a conventional subunit vaccine and the MF59-adjuvanted subunit influenza vaccine in the elderly: an evaluation of the safety, tolerability and immunogenicity","volume":"50","author":"Sindoni","year":"2009","journal-title":"J Prev Med Hyg"},{"key":"10.1016\/j.vaccine.2019.05.087_b0355","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1016\/j.vaccine.2003.10.007","article-title":"Leptospiral immunoglobulin-like proteins elicit protective immunity","volume":"22","author":"Koizumi","year":"2004","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.05.087_b0360","doi-asserted-by":"crossref","first-page":"4062","DOI":"10.1128\/IAI.73.7.4062-4069.2005","article-title":"Protection against Leptospira interrogans sensu lato challenge by DNA immunization with the gene encoding hemolysin-associated protein 1","volume":"73","author":"Branger","year":"2005","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2019.05.087_b0365","doi-asserted-by":"crossref","first-page":"6277","DOI":"10.1016\/j.vaccine.2007.05.053","article-title":"The terminal portion of leptospiral immunoglobulin-like protein LigA confers protective immunity against lethal infection in the hamster model of leptospirosis","volume":"25","author":"Silva","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.05.087_b0370","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0001422","article-title":"A LigA three-domain region protects hamsters from lethal infection by Leptospira interrogans","volume":"5","author":"Coutinho","year":"2011","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.vaccine.2019.05.087_b0375","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0180004","article-title":"Immunoprotective properties of recombinant LigA and LigB in a hamster model of acute leptospirosis","volume":"12","author":"Evangelista","year":"2017","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2019.05.087_b0380","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.1016\/j.vaccine.2009.12.071","article-title":"Identification and characterization of OmpA-like proteins as novel vaccine candidates for Leptospirosis","volume":"28","author":"Yan","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.05.087_b0385","doi-asserted-by":"crossref","first-page":"2574","DOI":"10.1016\/j.vaccine.2018.03.078","article-title":"LemA and Erp Y-like recombinant proteins from Leptospira interrogans protect hamsters from challenge using AddaVax\u2122 as adjuvant","volume":"36","author":"Oliveira","year":"2018","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.05.087_b0390","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1111\/j.0818-9641.2004.01272.x","article-title":"Vaccine adjuvants: current state and future trends","volume":"82","author":"Petrovsky","year":"2004","journal-title":"Immunol Cell Biol"},{"key":"10.1016\/j.vaccine.2019.05.087_b0395","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.jsps.2011.06.003","article-title":"Vaccine adjuvants - Current status and prospects on controlled release adjuvancity","volume":"19","author":"Sivakumar","year":"2011","journal-title":"Saudi Pharm J"},{"key":"10.1016\/j.vaccine.2019.05.087_b0400","first-page":"400","article-title":"A retrospective review of lesions associated with the use of Freund's adjuvant","volume":"39","author":"Broderson","year":"1989","journal-title":"Lab Anim Sci"},{"key":"10.1016\/j.vaccine.2019.05.087_b0405","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1093\/ilar.46.3.280","article-title":"Adjuvants and antibody production: dispelling the myths associated with Freund's complete and other adjuvants","volume":"46","author":"Stills","year":"2005","journal-title":"ILAR J"},{"key":"10.1016\/j.vaccine.2019.05.087_b0410","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.micpath.2018.08.028","article-title":"Antigenic potential of a recombinant polyvalent DNA vaccine against pathogenic leptospiral infection","volume":"124","author":"Garba","year":"2018","journal-title":"Microb Pathog"},{"key":"10.1016\/j.vaccine.2019.05.087_b0415","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1006\/cimm.1998.1283","article-title":"Dendritic cells internalize vaccine adjuvant after intramuscular injection","volume":"186","author":"Dupuis","year":"1998","journal-title":"Cell Immunol"},{"key":"10.1016\/j.vaccine.2019.05.087_b0420","doi-asserted-by":"crossref","first-page":"5402","DOI":"10.4049\/jimmunol.180.8.5402","article-title":"The adjuvants aluminum hydroxide and MF59 induce monocyte and granulocyte chemoattractants and enhance monocyte differentiation toward dendritic cells","volume":"180","author":"Seubert","year":"2008","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2019.05.087_b0425","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1586\/erv.10.111","article-title":"MF59\u2122 as a vaccine adjuvant: a review of safety and immunogenicity","volume":"9","author":"El Sahly","year":"2010","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2019.05.087_b0430","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1004004","article-title":"A model system for studying the transcriptomic and physiological changes associated with mammalian host-adaptation by Leptospira interrogans serovar Copenhageni","volume":"10","author":"Caimano","year":"2014","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.vaccine.2019.05.087_b0435","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S1074-7613(00)80310-6","article-title":"Identification of an H2-M3-restricted Listeria epitope: implications for antigen presentation by M3","volume":"5","author":"Lenz","year":"1996","journal-title":"Immunity"},{"key":"10.1016\/j.vaccine.2019.05.087_b0440","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1128\/CVI.00034-13","article-title":"A prime-boost strategy using the novel vaccine candidate, LemA, protects hamsters against leptospirosis","volume":"20","author":"Hartwig","year":"2013","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.vaccine.2019.05.087_b0445","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.vetmic.2012.08.019","article-title":"The OmpA family of proteins: roles in bacterial pathogenesis and immunity","volume":"163","author":"Confer","year":"2013","journal-title":"Vet Microbiol"},{"key":"10.1016\/j.vaccine.2019.05.087_b0450","doi-asserted-by":"crossref","first-page":"7379","DOI":"10.1016\/j.vaccine.2011.07.070","article-title":"Evaluation of novel fusion proteins derived from extracellular matrix binding domains of LigB as vaccine candidates against leptospirosis in a hamster model","volume":"29","author":"Cao","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.05.087_b0455","first-page":"827","article-title":"Adjuvant effect of bacterial LPS and\/or alum precipitation in responses to polysaccharide and protein antigens","volume":"53","author":"Sepp\u00e4l\u00e4","year":"1984","journal-title":"Immunology"},{"key":"10.1016\/j.vaccine.2019.05.087_b0460","doi-asserted-by":"crossref","first-page":"221","DOI":"10.2174\/187153012802002884","article-title":"The role of bacterial lipopolysaccharides as immune modulator in vaccine and drug development","volume":"12","author":"Arenas","year":"2012","journal-title":"Endocr Metab Immune Disord Drug Targets"},{"key":"10.1016\/j.vaccine.2019.05.087_b0465","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/j.cell.2006.02.015","article-title":"Pathogen recognition and innate immunity","volume":"124","author":"Akira","year":"2006","journal-title":"Cell"},{"issue":"Suppl 5","key":"10.1016\/j.vaccine.2019.05.087_b0470","doi-asserted-by":"crossref","first-page":"S512","DOI":"10.1093\/clinids\/9.Supplement_5.S512","article-title":"Characterization of a nontoxic monophosphoryl lipid A","volume":"9","author":"Johnson","year":"1987","journal-title":"Rev Infect Dis"},{"key":"10.1016\/j.vaccine.2019.05.087_b0475","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.immuni.2010.10.002","article-title":"Vaccine adjuvants: putting innate immunity to work","volume":"33","author":"Coffman","year":"2010","journal-title":"Immunity"},{"key":"10.1016\/j.vaccine.2019.05.087_b0480","unstructured":"Raw I, Kubrusly FS, Iourtov D, Sakauchi MA, dos Santos FL, Darini E, et al. Method to obtain monophosphoryl lipid a from bordetella pertussis as a by-product of the cellular pertussis vaccine production WO 2008134830 A1; 2008."},{"key":"10.1016\/j.vaccine.2019.05.087_b0485","doi-asserted-by":"crossref","first-page":"926","DOI":"10.4049\/jimmunol.168.2.926","article-title":"Monophosphoryl lipid A activates both human dendritic cells and T cells","volume":"168","author":"Ismaili","year":"2002","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2019.05.087_b0490","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0056855","article-title":"TRIF is required for TLR4 mediated adjuvant effects on T cell clonal expansion","volume":"8","author":"Gandhapudi","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2019.05.087_b0495","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1189\/jlb.0305172","article-title":"The low-toxicity versions of LPS, MPL adjuvant and RC529, are efficient adjuvants for CD4+ T cells","volume":"78","author":"Thompson","year":"2005","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.vaccine.2019.05.087_b0500","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1038\/nri1391","article-title":"Toll-like receptor signalling","volume":"4","author":"Akira","year":"2004","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.vaccine.2019.05.087_b0505","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1080\/14760584.2018.1457443","article-title":"Flagellin as a vaccine adjuvant","volume":"17","author":"Cui","year":"2018","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2019.05.087_b0510","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.vaccine.2007.10.062","article-title":"Potent immunogenicity and efficacy of a universal influenza vaccine candidate comprising a recombinant fusion protein linking influenza M2e to the TLR5 ligand flagellin","volume":"26","author":"Huleatt","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.05.087_b0515","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1128\/IAI.74.2.1113-1120.2006","article-title":"Flagellin is an effective adjuvant for immunization against lethal respiratory challenge with Yersinia pestis","volume":"74","author":"Honko","year":"2006","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2019.05.087_b0520","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1089\/vim.2009.0107","article-title":"A recombinant flagellin-poxvirus fusion protein vaccine elicits complement-dependent protection against respiratory challenge with vaccinia virus in mice","volume":"23","author":"Delaney","year":"2010","journal-title":"Viral Immunol"},{"key":"10.1016\/j.vaccine.2019.05.087_b0525","doi-asserted-by":"crossref","first-page":"2356","DOI":"10.1128\/IAI.00054-09","article-title":"A fusion protein vaccine containing OprF epitope 8, OprI, and type A and B flagellins promotes enhanced clearance of nonmucoid Pseudomonas aeruginosa","volume":"77","author":"Weimer","year":"2009","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2019.05.087_b0530","doi-asserted-by":"crossref","first-page":"2775","DOI":"10.1128\/IAI.68.5.2775-2782.2000","article-title":"Parenteral adjuvant activities of Escherichia coli heat-labile toxin and its B subunit for immunization of mice against gastric Helicobacter pylori infection","volume":"68","author":"Weltzin","year":"2000","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2019.05.087_b0535","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1046\/j.1365-2567.1997.00291.x","article-title":"Modulation of B-cell activation by the B subunit of Escherichia coli enterotoxin: receptor interaction up-regulates MHC class II, B7, CD40, CD25 and ICAM-1","volume":"91","author":"Nashar","year":"1997","journal-title":"Immunology"},{"key":"10.1016\/j.vaccine.2019.05.087_b0540","doi-asserted-by":"crossref","first-page":"5301","DOI":"10.4049\/jimmunol.159.11.5301","article-title":"The mucosal adjuvanticity of cholera toxin involves enhancement of costimulatory activity by selective up-regulation of B7.2 expression","volume":"159","author":"Cong","year":"1997","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2019.05.087_b0545","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1086\/315694","article-title":"Enterotoxin adjuvants have direct effects on T cells and antigen-presenting cells that result in either interleukin-4-dependent or -independent immune responses","volume":"182","author":"Yamamoto","year":"2000","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2019.05.087_b0550","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1139\/W08-056","article-title":"B subunit of Escherichia coli heat-labile enterotoxin as adjuvant of humoral immune response in recombinant BCG vaccination","volume":"54","author":"da Silva Ramos Rocha","year":"2008","journal-title":"Can J Microbiol."},{"key":"10.1016\/j.vaccine.2019.05.087_b0555","doi-asserted-by":"crossref","first-page":"230","DOI":"10.5662\/wjm.v5.i4.230","article-title":"Recombinant outer membrane protein F-B subunit of LT protein as a prophylactic measure against Pseudomonas aeruginosa burn infection in mice","volume":"5","author":"Farsani","year":"2015","journal-title":"World J Methodol"},{"key":"10.1016\/j.vaccine.2019.05.087_b0560","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/j.vaccine.2015.12.039","article-title":"Recombinant baculovirus vaccine containing multiple M2e and adjuvant LTB induces T cell dependent, cross-clade protection against H5N1 influenza virus in mice","volume":"34","author":"Zhang","year":"2016","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.05.087_b0565","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1128\/CVI.05720-11","article-title":"Protection against lethal leptospirosis after vaccination with LipL32 coupled or coadministered with the B subunit of Escherichia coli heat-labile enterotoxin","volume":"19","author":"Grassmann","year":"2012","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.vaccine.2019.05.087_b0570","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/S0065-2776(08)60790-7","article-title":"Bacterial CpG DNA activates immune cells to signal infectious danger","volume":"73","author":"Wagner","year":"1999","journal-title":"Adv Immunol"},{"key":"10.1016\/j.vaccine.2019.05.087_b0575","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1038\/35047123","article-title":"A Toll-like receptor recognizes bacterial DNA","volume":"408","author":"Hemmi","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2019.05.087_b0580","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1128\/IAI.68.3.1450-1456.2000","article-title":"CpG oligodeoxynucleotides act as adjuvants for pneumococcal polysaccharide-protein conjugate vaccines and enhance antipolysaccharide immunoglobulin G2a (IgG2a) and IgG3 antibodies","volume":"68","author":"Chu","year":"2000","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2019.05.087_b0585","doi-asserted-by":"crossref","first-page":"15553","DOI":"10.1073\/pnas.95.26.15553","article-title":"CpG DNA can induce strong Th1 humoral and cell-mediated immune responses against hepatitis B surface antigen in young mice","volume":"95","author":"Brazolot Millan","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.vaccine.2019.05.087_b0590","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1046\/j.1365-2567.2001.01158.x","article-title":"Adjuvant effects of CpG oligodeoxynucleotides on responses against T-independent type 2 antigens","volume":"102","author":"Kovarik","year":"2001","journal-title":"Immunology"},{"key":"10.1016\/j.vaccine.2019.05.087_b0595","doi-asserted-by":"crossref","DOI":"10.3390\/v9120378","article-title":"Protection of mice from lethal vaccinia virus infection by vaccinia virus protein subunits with a CpG adjuvant","volume":"9","author":"Reeman","year":"2017","journal-title":"Viruses"},{"key":"10.1016\/j.vaccine.2019.05.087_b0600","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.02257-16","article-title":"Prophylactic herpes simplex virus 2 (HSV-2) vaccines adjuvanted with stable emulsion and toll-like receptor 9 agonist induce a robust HSV-2-specific cell-mediated immune response, protect against symptomatic disease, and reduce the latent viral reservoir","volume":"91","author":"Hensel","year":"2017","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2019.05.087_b0605","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/636491","article-title":"Xanthan gum as an adjuvant in a subunit vaccine preparation against leptospirosis","volume":"2014","author":"Bacelo","year":"2014","journal-title":"Biomed Res Int"},{"key":"10.1016\/j.vaccine.2019.05.087_b0610","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0167-7799(97)01139-6","article-title":"Novel and established applications of microbial polysaccharides","volume":"16","author":"Sutherland","year":"1998","journal-title":"Trends Biotechnol"},{"key":"10.1016\/j.vaccine.2019.05.087_b0615","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1002\/eji.1830130309","article-title":"Immune responses to xanthan gum. I. The characteristics of lymphocyte activation by xanthan gum","volume":"13","author":"Ishizaka","year":"1983","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.vaccine.2019.05.087_b0620","doi-asserted-by":"crossref","first-page":"5862","DOI":"10.1016\/j.biomaterials.2009.06.046","article-title":"Mucoadhesive liposomes for intranasal immunization with an avian influenza virus vaccine in chickens","volume":"30","author":"Chiou","year":"2009","journal-title":"Biomaterials"},{"key":"10.1016\/j.vaccine.2019.05.087_b0625","doi-asserted-by":"crossref","first-page":"5535","DOI":"10.1128\/IAI.72.10.5535-5547.2004","article-title":"Enteric pathogens as vaccine vectors for foreign antigen delivery","volume":"72","author":"Kotton","year":"2004","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2019.05.087_b0630","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1128\/IAI.01533-13","article-title":"Oral immunization with Escherichia coli expressing a lipidated form of LigA protects hamsters against challenge with Leptospira interrogans serovar Copenhageni","volume":"82","author":"Lourdault","year":"2014","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2019.05.087_b0635","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.vaccine.2007.10.052","article-title":"Recombinant Mycobacterium bovis BCG expressing the LipL32 antigen of Leptospira interrogans protects hamsters from challenge","volume":"26","author":"Seixas","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.05.087_b0640","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1038\/252252a0","article-title":"Liposomes as immunological adjuvants","volume":"252","author":"Allison","year":"1974","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2019.05.087_b0645","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics8010007","article-title":"Liposome-based adjuvants for subunit vaccines: formulation strategies for subunit antigens and immunostimulators","volume":"8","author":"Tandrup Schmidt","year":"2016","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.vaccine.2019.05.087_b0650","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.imlet.2009.10.005","article-title":"The ABC of clinical and experimental adjuvants\u2013a brief overview","volume":"128","author":"Brunner","year":"2010","journal-title":"Immunol Lett"},{"key":"10.1016\/j.vaccine.2019.05.087_b0655","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1586\/erv.10.89","article-title":"Nano-microparticles as immune adjuvants: correlating particle sizes and the resultant immune responses","volume":"9","author":"Oyewumi","year":"2010","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2019.05.087_b0660","doi-asserted-by":"crossref","first-page":"5235","DOI":"10.1128\/IAI.72.9.5235-5246.2004","article-title":"Activation of dendritic cells by liposomes prepared from phosphatidylinositol mannosides from Mycobacterium bovis bacillus Calmette-Guerin and adjuvant activity in vivo","volume":"72","author":"Sprott","year":"2004","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2019.05.087_b0665","doi-asserted-by":"crossref","first-page":"5817","DOI":"10.1128\/IAI.73.9.5817-5826.2005","article-title":"Cationic liposomes containing mycobacterial lipids: a new powerful Th1 adjuvant system","volume":"73","author":"Rosenkrands","year":"2005","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2019.05.087_b0670","doi-asserted-by":"crossref","first-page":"6129","DOI":"10.1016\/j.vaccine.2009.08.029","article-title":"Immune response and prophylactic efficacy of smegmosomes in a hamster model of leptospirosis","volume":"27","author":"Faisal","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.05.087_b0675","doi-asserted-by":"crossref","first-page":"6537","DOI":"10.1016\/j.vaccine.2009.08.051","article-title":"Leptosome-entrapped leptospiral antigens conferred significant higher levels of protection than those entrapped with PC-liposomes in a hamster model","volume":"27","author":"Faisal","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.05.087_b0680","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.vaccine.2008.10.089","article-title":"Leptospira immunoglobulin-like protein A variable region (LigAvar) incorporated in liposomes and PLGA microspheres produces a robust immune response correlating to protective immunity","volume":"27","author":"Faisal","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.05.087_b0685","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1615\/CritRevTherDrugCarrierSyst.2018014419","article-title":"Biomedical applications and toxicological aspects of functionalized carbon nanotubes","volume":"35","author":"Mishra","year":"2018","journal-title":"Crit Rev Ther Drug Carrier Syst"},{"key":"10.1016\/j.vaccine.2019.05.087_b0690","article-title":"Biomedical applications of functionalised carbon nanotubes","volume":"571\u20137","author":"Bianco","year":"2005","journal-title":"Chem Commun (Camb)"},{"key":"10.1016\/j.vaccine.2019.05.087_b0695","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.bbamem.2005.10.008","article-title":"Functionalized carbon nanotubes as emerging nanovectors for the delivery of therapeutics","volume":"1758","author":"Klumpp","year":"2006","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.vaccine.2019.05.087_b0700","doi-asserted-by":"crossref","first-page":"11600","DOI":"10.1073\/pnas.0502680102","article-title":"Carbon nanotubes as multifunctional biological transporters and near-infrared agents for selective cancer cell destruction","volume":"102","author":"Kam","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.vaccine.2019.05.087_b0705","doi-asserted-by":"crossref","DOI":"10.1371\/annotation\/1801d3b3-2082-4eb7-913b-b93e1fe4c219","article-title":"Phosphatidylserine targets single-walled carbon nanotubes to professional phagocytes in vitro and in vivo","volume":"4","author":"Konduru","year":"2009","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2019.05.087_b0710","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1590\/0074-02760140276","article-title":"The use of halloysite clay and carboxyl-functionalised multi-walled carbon nanotubes for recombinant LipL32 antigen delivery enhanced the IgG response","volume":"110","author":"Hartwig","year":"2015","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"10.1016\/j.vaccine.2019.05.087_b0715","first-page":"207","article-title":"Defective adenoviruses as virus vectors for veterinary vaccines","volume":"26","author":"Eloit","year":"1995","journal-title":"Vet Res"},{"key":"10.1016\/j.vaccine.2019.05.087_b0720","doi-asserted-by":"crossref","first-page":"6831","DOI":"10.1128\/IAI.69.11.6831-6838.2001","article-title":"Identification of the hemolysis-associated protein 1 as a cross-protective immunogen of Leptospira interrogans by adenovirus-mediated vaccination","volume":"69","author":"Branger","year":"2001","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2019.05.087_b0725","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1517\/13543784.7.9.1475","article-title":"QS-21: a water-soluble triterpene glycoside adjuvant","volume":"7","author":"Kensil","year":"1998","journal-title":"Expert Opin Investig Drugs"},{"key":"10.1016\/j.vaccine.2019.05.087_b0730","doi-asserted-by":"crossref","first-page":"79","DOI":"10.2174\/1874285801206010079","article-title":"Evaluation of immunoprotective activity of six leptospiral proteins in the hamster model of leptospirosis","volume":"6","author":"Atzingen","year":"2012","journal-title":"Open Microbiol J"},{"key":"10.1016\/j.vaccine.2019.05.087_b0735","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1007\/s00284-013-0505-4","article-title":"Mannosylated LigANI produced in Pichia pastoris protects hamsters against leptospirosis","volume":"68","author":"Hartwig","year":"2014","journal-title":"Curr Microbiol"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X19307340?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X19307340?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:33:31Z","timestamp":1759401211000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X19307340"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7]]},"references-count":147,"journal-issue":{"issue":"30","published-print":{"date-parts":[[2019,7]]}},"alternative-id":["S0264410X19307340"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2019.05.087","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2019,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Adjuvanted leptospiral vaccines: Challenges and future development of new leptospirosis vaccines","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2019.05.087","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}